Physician profile
Rickyn Patel
NPI 1972821825
$2,789.70
in general payments reported to CMS, 2019-2025
15 companies · $193 in 2025
The $193 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $374 · 2020: $30.38 · 2021: $170 · 2022: $313 · 2023: $534 · 2024: $1,176 · 2025: $193.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,186 · Travel and Lodging: $716.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,186.44 |
| Travel and Lodging | $715.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,251.22 | 2019-2025 | Mitraclip, Triclip |
| Novartis Pharmaceuticals Corporation | $804.70 | 2019-2023 | |
| Astrazeneca Pharmaceuticals Lp | $244.58 | 2021-2023 | Farxiga |
| Inari Medical, INC. | $133.64 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Medtronic, INC. | $83.91 | 2024 | Azure Xt Dr Mri Surescan |
| Pfizer INC. | $46.71 | 2023 | |
| Scpharmaceuticals INC. | $38.01 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $30.96 | 2023 | Eliquis |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $30.58 | 2020-2023 | Lifevest |
| Esperion Therapeutics, INC. | $30.42 | 2023 | Nexletol |
| Boston Scientific Corporation | $27.74 | 2025 | Watchman Flx |
| Kiniksa Pharmaceuticals, Ltd. | $20.47 | 2023 | Arcalyst |
| Kiniksa Pharmaceuticals International, Plc | $18.00 | 2024 | Arcalyst |
| Janssen Pharmaceuticals, INC | $14.44 | 2022 | |
| Lexicon Pharmaceuticals, INC. | $14.32 | 2023 | Inpefa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rickyn Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.